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IntroductIon
The prevalence of type 2 diabetes is increasing globally at an 
alarming rate (1), and this problem is particularly severe in pop-
ulations of African descent. Results from the Atherosclerosis 
Risk in Communities (ARIC) study of over 10,000 Americans 
reveal that African American (AA) women and men have a 
2.4-fold and 1.5-fold greater incidence of type 2 diabetes than 
their European-American (EA) counterparts (2), which is only 
partially related to the increased prevalence of obesity seen in 
AA, suggesting that other factors play a role (3).
Insulin resistance, a central pathophysiological feature in the 
initiation and progression toward type 2 diabetes, is associ-
ated with obesity; however, general adiposity can explain only 
a small percentage of the interindividual variability in insulin 
sensitivity observed in nondiabetic individuals (4). Total body 
fat distribution or lipid accumulation within muscle or hepatic 
cells can exist independently of generalized adiposity and can 
also contribute to insulin resistance (5–7). Several studies have 
found that insulin sensitivity is negatively associated with 
adipose stores in the abdominal region, particularly visceral 
adipose tissue (VAT), and this is consistent across age and eth-
nicity (8,9). Surprisingly, however, AA adults have significantly 
lower levels of VAT than their EA counterparts, despite having 
a higher prevalence of insulin resistance and type 2 diabetes. 
Studies of ethnic differences in fat distribution show that, even 
when controlling for total fat and BMI, AA women have signif-
icantly less VAT than EA women (10), which persists even after 
significant weight gain (11) and weight loss (12). Furthermore, 
AA youth carry less VAT than their EA peers, indicating that 
this difference is independent of age (13).
Similarly, both AA adolescents (13) and adults (14) have very 
little hepatic fat compared to EA. AA adults also have a sub-
stantially lower prevalence of nonalcoholic fatty liver disease 
than EA (15). Thus, neither visceral nor hepatic fat depots can 
explain the higher prevalence of insulin resistance observed in 
the AA population. However, it is possible that fat depots other 
than VAT and hepatic fat contribute to insulin resistance and 
greater type 2 diabetes prevalence among AA relative to EA.
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Insulin resistance has been associated with the accumulation of fat within skeletal muscle fibers as intramyocellular 
lipid (IMCL). Here, we have examined in a cross-sectional study the interrelationships among IMCL, insulin sensitivity, 
and adiposity in European Americans (EAs) and African Americans (AAs). In 43 EA and 43 AA subjects, we measured 
soleus IMCL content with proton-magnetic resonance spectroscopy, insulin sensitivity with hyperinsulinemic–
euglycemic clamp, and body composition with dual-energy X-ray absorptiometry. The AA and EA subgroups had 
similar IMCL content, insulin sensitivity, and percent fat, but only in EA was IMCL correlated with insulin sensitivity 
(r = −0.47, P < 0.01), BMI (r = 0.56, P < 0.01), percent fat (r = 0.35, P < 0.05), trunk fat (r = 0.47, P < 0.01), leg fat 
(r = 0.40, P < 0.05), and waist and hip circumferences (r = 0.54 and 0.55, respectively, P < 0.01). In a multiple regression 
model including IMCL, race, and a race by IMCL interaction, the interaction was found to be a significant predictor 
(t = 1.69, DF = 1, P = 0.0422). IMCL is related to insulin sensitivity and adiposity in EA but not in AA, suggesting that 
IMCL may not function as a pathophysiological factor in individuals of African descent. These results highlight ethnic 
differences in the determinants of insulin sensitivity and in the pathogenesis of the metabolic syndrome trait cluster.
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Several studies have reported an inverse relationship between 
intramyocellular lipid (IMCL) and insulin sensitivity in inac-
tive individuals, independent of measures of general adipos-
ity in both animal (16) and human models (17). Furthermore, 
IMCL is elevated in patients with both type 1 and type 2 diabe-
tes (18), as well as in populations that are prone to developing 
type 2 diabetes, such as Pima Indians (19) and offspring of par-
ents with type 2 diabetes (6,18). Moreover, the improvement in 
insulin sensitivity observed after a short-term hypocaloric diet 
was explained by a decrease in IMCL rather than by changes in 
total adiposity in both nondiabetic patients and patients with 
type 2 diabetes (4). Similar improvements in insulin sensitiv-
ity were observed in parallel with IMCL depletion in morbidly 
obese subjects after surgical treatment of obesity (20). These 
findings highlight the importance of IMCL as a metabolically 
active fat depot that influences glucose metabolism independ-
ently of total body adiposity. The objective of this study was 
to determine whether racial differences exist in the relation-
ships linking IMCL, insulin sensitivity, and body composition, 
including measurements of total and regional adiposity.
Methods and Procedures
subject characteristics
The study subjects were recruited from advertisements and word-of-
mouth referrals. Those meeting inclusion requirements and providing 
informed consent were sequentially enrolled and studied. However, an 
effort was made to have equal enrollment of European- and African-
Americans such that only AAs were entered into the study after the full 
complement of EAs had been recruited. The final study group comprised 
86 volunteers (43 EA and 43 AA) with ages between 21 and 59 years.
The clinical characteristics of the study group are listed in Table 1. 
Subjects were admitted to a metabolic ward, the Participant and Clini-
cal Interaction Resources of the University of Alabama at Birmingham 
(UAB) Center for Clinical and Translational Science, where they received 
a eucaloric diet during the length of stay (3 days) comprising 20% pro-
tein, 30% fat, and 50% carbohydrate calories. Weight was stable (±3%) 
for at least 3 months before study, BMI was between 21 and 46, and none 
of the study subjects engaged in regular exercise. None of the volunteers 
had cardiovascular, renal, or hepatic disease, and all were chemically 
euthyroid. No subjects were ingesting pharmacological agents known to 
affect carbohydrate homeostasis, lipids, or body composition. Race was 
determined by self-report. Protocols were approved by the institutional 
review board, and written informed consent was obtained from every 
subject. Subjects underwent evaluation as described below.
Insulin sensitivity
In vivo insulin sensitivity was assessed using the euglycemic–hyperin-
sulinemic glucose clamp technique at a maximally effective steady-state 
serum insulin concentration as previously described (21). Briefly, after 
a 12-h fast, a catheter was inserted into the brachial vein to adminis-
ter insulin, glucose, and KPO4. A dorsal hand vein was cannulated 
in a retrograde manner and kept in a warming device (65 °C) to pro-
vide arterialized venous blood for sampling. To maximally stimulate 
 skeletal muscle glucose uptake and suppress hepatic glucose produc-
tion, we administered regular insulin (Humulin; Eli Lilly, Indianapolis, 
IN) at a rate of 200 mU·m−2·min−1, producing a mean steady-state insu-
lin concentration of 3,480 ± 138 pmol/l, which is maximally effective 
for suppressing hepatic glucose production and reflects maximally 
stimulated skeletal muscle glucose uptake (22). Serum glucose was 
clamped at 5.0 mmol/l for at least 3 h, and maximal glucose uptake for 
each individual was calculated from the mean glucose infusion rate 
over the final three 20-min interval. Whole-body glucose uptake was 
calculated based on the glucose infusion rate corrected for changes in 
the glucose pool size, assuming a distribution volume of 19% body 
weight and a pool fraction of 0.65. Glucose uptake was normalized 
per kilogram lean body mass (excluding bone mass) determined by 
dual-energy X-ray absorptiometry scanning to yield the glucose dis-
posal rate per kilogram of lean body mass (GDR). Lower GDR values 
indicate greater insulin resistance. Of the 86 subjects tested, nine sub-
jects (five AA and four EA females) were missing GDR data because 
of mechanical difficulties with intravenous filtration, difficulties with 
blood draw, or patient request to discontinue test.
IMcL
IMCL was quantified using 1H magnetic resonance spectroscopy. 
1H magnetic resonance spectroscopy is a reliable and noninvasive tech-
nique for measuring IMCL (23). It correlates with fluorescence micro-
scopy of Oil Red O staining, however, it does not provide information 
about lipid compartmentalization within the muscle cell (24).
All subjects were studied on a Philips 3T system (Philips Medical 
Systems, Best, The Netherlands). IMCL was measured using a point-
resolved spectroscopy single voxel acquisition sequence with a com-
mercially provided 1H transmit/receive torso phased-array coil (Philips 
Medical Systems). Legs were positioned inside this commercial torso 
coil with knees extended and ankles secured in a neutral position. The 
water-suppressed point-resolved spectroscopy voxels (1 cm × 1 cm × 
1 cm voxel size) were positioned in the soleus muscle in areas that avoid 
fascia, vascular structures, and gross marbling. All point-resolved spec-
troscopy acquisitions utilized the following parameters to collect the 
IMCL data: repetition time = 2000 ms, echo time = 40 ms, and 128 signal 
averages. Separate non-water–suppressed spectra were also collected 
with the same repetition time/echo time but only 16 signal averages as 
an amplitude reference. All IMCL and internal water spectra were cor-
rected for T1 and T2 relaxation as well as normalized for point-resolved 
spectroscopy voxel sizes and number of signal averages.
table 1 Body composition and metabolic characteristics of 
study subjects by race
Variable
EA adults AA adults
P valueN = 43 (14 M/29 F) N = 43 (14 M/29 F)
Age (years) 39.0 ± 11 (20–60) 37.6 ± 10 (22–56) 0.64
Weight (kg) 83.8 ± 16 (61–136) 90.5 ± 17 (65–132) 0.06
BMI (kg/m2)a 29.3 ± 5.8 (21–46) 31.8 ± 5.2 (22–43) 0.04
% Body fat (DXA)b 38.8 ± 12 (7–55) 39.9 ± 9.4 (16–53) 0.64
Trunk fat (kg)b 16.8 ± 7.0 (4.2–36) 18.2 ± 7.1 (6.3–41) 0.35
Leg fat (kg)b 5.9 ± 2.6 (1.4–13) 6.90 ± 2.6 (2.3–14) 0.08
Trunk/leg ratiob 2.94 ± 0.7 (1.5–5.2) 2.74 ± 0.6 (1.3–4.0) 0.17
Waist (cm)b 93.5 ± 13 (74–131) 98.1 ± 12 (75–122) 0.10
Hip (cm)b 108 ± 13 (88–149) 111 ± 9.6 (94–134) 0.25
Waist/hip ratiob 0.86 ± 0.1 (0.7–1.0) 0.88 ± 0.1 (0.7–1.1) 0.28
GDR  
(mg/kgLBM/min)c
14.3 ± 4.2 (7.2–22) 13.9 ± 3.3 (5.6–21) 0.67
Fasting insulin  
(µU/ml)d
16.2 ± 14 (4.1–87) 16.4 ± 12 (5.3–53) 0.96
Fasting glucose  
(mg/dl)e
93.9 ± 8.4 (78–117) 92.3 ± 10 (76–113) 0.43
IMCL (AU) 2.39 ± 1.8 (0.2–7.1) 2.61 ± 1.7 (0.4–7.1) 0.57
Results are mean ± s.d. (range). N = 43 EA and 43 AA, unless specified otherwise.
AA, African American; AU, arbitrary units; DXA, dual-energy X-ray absorptiom-
etry; EA, European American; GDR, maximally stimulated glucose disposal rate; 
IMCL, intramyocellular lipid content.
aDifference between EA and AA, P < 0.05. bN = 42 EA, 42 AA. cN = 39 EA, 38 AA. 
dN = 35 EA, 33 AA. eN = 43 EA, 41 AA.
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Spectra were analyzed by fitting the peak positions and areas through 
time domain fitting using Java-Based Magnetic Resonance User Interface 
(jMRUI) (25). IMCL content in the soleus spectra was fit using previously 
published fitting models and sets of prior knowledge information (23). All 
peak areas in this study are expressed in arbitrary units/pixel area relative to 
internal water. Although we cannot absolutely quantify our lipid measure-
ments with these methods, the use of the internal water as an intensity refer-
ence allow us to determine differences in lipid contents among subjects.
anthropometric and body composition measurements
BMI was calculated as body weight in kilograms divided by the square of 
height in meters (kg/m2). Fat distribution was assessed by waist and hip 
circumferences (cm) using a tension-controlled tape measure by Novel 
Products (Rockton, IL). Dual-energy X-ray absorptiometry scanning was 
performed using Prodigy (GE Medical Systems LUNAR, Madison, WI) 
with the use of software version 6.10.029 (enCORE 2002) and provided 
body composition measures including total body fat, trunk fat, leg fat, 
percentage of body fat, and lean body mass independent of bone mass.
statistical analyses
Differences between AA and EA in variables of interest were compared 
using univariate ANOVA. Relationships among IMCL and different 
metabolic and anthropometric variables in both ethnic groups were 
examined using Pearson correlation coefficients and were controlled 
for age and gender.
Multiple regression analysis was used to determine whether the rela-
tionship between GDR and IMCL varies between races. Anthropometric 
measures were not included in the regression model because of the col-
linearity of the anthropometric measures and other predictors. Missing 
data were handled by pairwise deletion. Analyses were performed using 
SPSS 17.0 for Windows (SPSS, Chicago, IL) and differences were accepted 
as significant at P < 0.05.
In the initial multiple regression between IMCL, race, their interac-
tion, and GDR, residual plots indicated that homoscedasticity was most 
likely violated. To alleviate this problem, we imposed a heteroscedasticity-
consistent covariance matrix (HC2 method in Proc Reg).
resuLts
General characteristics of study subjects
The subject characteristics are summarized in Table 1. As 
shown in this table, BMI was slightly higher in the AA group 
compared with EA, but no significant differences existed for 
insulin sensitivity, IMCL, body weight, percent fat, trunk fat, 
or waist or hip circumferences. Thus, although the groups dif-
fered slightly in BMI, EA and AA were well matched for overall 
age, percent fat, IMCL, and insulin sensitivity.
relationships between IMcL, metabolism,  
and body composition
Correlations between IMCL, GDR, and body composition 
parameters were controlled for age and gender and are listed in 
Table 2. In EA, IMCL was widely related to measures of general-
ized and regional adiposity and insulin sensitivity. In contrast, in 
AA, IMCL was not correlated with any of the variables measured. 
IMCL was inversely associated with GDR and positively related 
to waist circumference, BMI, and percent fat in EA, whereas these 
relations were not statistically significant in AA (Figure 1).
IMCL remained negatively correlated with GDR in EA 
(r = −0.36, P = 0.03) and not in AA (r = −0.17, P = 0.33), when 
the relationship was controlled for BMI. The correlations in EA 
between percent fat, trunk fat, leg fat, waist circumference, and 
hip circumference with IMCL or GDR were reduced to nonsig-
nificant levels when BMI was controlled. This result is predict-
able based on the collinearity of BMI to the other measures of 
adiposity. The correlations between GDR and trunk-to-leg fat 
ratio in EA and waist-to-hip ratio in AA changed slightly and 
remained significant, whereas the correlation between GDR and 
waist-to-hip ratio in EA was reduced to a nonsignificant level.
Self-reported race was found to significantly affect the rela-
tionship between IMCL and GDR (race by IMCL interaction; 
t = 1.69, DF = 1, P = 0.04), although the individual race vari-
able was not significant (t = −1.51, DF = 1, P = 0.11).
dIscussIon
The purpose of this study was to assess racial differences in the 
relationships among IMCL, insulin sensitivity, and adiposity 




IMCL N GDR N IMCL N GDR N
IMCL (AU) — 43 −0.47** 39 — 43 −0.17 38
GDR (mg/kgLBM/min) −0.47** 39 — 39 −0.17 38 — 38
BMI (kg/m2) 0.53** 43 −0.35* 39 0.04 43 −0.42** 38
% Body fat (DXA) 0.31* 38 −0.33* 39 0.00 42 −0.13 37
Trunk fat (kg) 0.43** 38 −0.39* 39 −0.12 42 −0.38* 37
Leg fat (kg) 0.37** 38 −0.23 39 −0.11 42 −0.20 37
Trunk/leg ratio 0.20 38 −0.40* 39 0.06 42 −0.37* 37
Waist (cm) 0.53** 38 −0.41** 39 0.04 42 −0.48** 37
Hip (cm) 0.51** 38 −0.35* 39 0.00 42 −0.17 37
Waist/hip ratio 0.25 38 −0.29 39 0.14 42 −0.51** 37
Significant values are in boldface. Estimates and significance tests are controlled for age and gender.
AA, African American; AU, arbitrary units; DXA, dual-energy X-ray absorptiometry; EA, European American; GDR, maximally stimulated glucose disposal rate; 
IMCL, intramyocellular lipid content.
*P ≤ 0.05, **P ≤ 0.01.
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in AA and EA adults. In particular, we (26,27) and others 
(2,3,28) have reported racial differences in the metabolic syn-
drome trait cluster, however, no data have addressed whether 
IMCL is a determinant of insulin resistance in AA adults as 
has been reported in EA. To our knowledge, this is the first 
study to definitively assess the role of ethnicity on the relation-
ship between IMCL, insulin sensitivity, and body composition 
in EA and AA adults. We assessed insulin sensitivity as GDR 
using the gold-standard hyperinsulinemic–euglycemic clamp, 
IMCL content by proton-magnetic resonance spectroscopy, 
and total and regional body composition by dual-energy 
X-ray absorptiometry and circumferences. Mean values for 
adiposity, body composition, IMCL, and insulin sensitivity 
were equivalent in our EA and AA subgroups; however, we 
found marked racial differences in the relationships between 
IMCL and metabolic and adiposity parameters.
When we analyzed the main effects of IMCL and ethnicity, we 
found no evidence of an ethnic difference in insulin sensitivity, 
which is consistent with previous studies using the euglycemic 
clamp method of measuring insulin sensitivity (22,29). When 
we accounted for the interaction between IMCL and ethnic-
ity, however, our data revealed an ethnic difference in insulin 
sensitivity (GDR) which is dependent upon IMCL content. We 
found that, at lower IMCL levels, AAs and EAs have similar 
levels of insulin sensitivity. At higher levels of IMCL, AAs are 
respectively more insulin sensitive.
IMCL was significantly and negatively related to insulin sen-
sitivity in EA independent of BMI, supporting previous find-
ings on the relationship between insulin sensitivity and IMCL 
(19,30). This is also consistent with a previous study in lean 
nondiabetic offspring of patients with type 2 diabetes which 
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Figure 1 Relationships between intramyocellular lipid (IMCL) and insulin resistance, waist circumference, and BMI in American adults of European-
American (EA) and African-American (AA) descent. The figures show correlations between IMCL as measured by proton-nuclear magnetic resonance 
spectroscopy and (a,b) glucose disposal rate (GDR) assessed using the euglycemic–hyperinsulinemic glucose clamp technique, (c,d) waist 
circumference, and (e,f) BMI in EA and AA, respectively. Empty circles represent EA values and filled circles represent AA values. Race was 
determined by self-report. AU, arbitrary units.
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higher IMCL content than insulin-sensitive offspring matched 
for age, sex, BMI, percent fat, waist-to-hip ratio, and physical 
fitness (6). In AA, on the other hand, IMCL was not correlated 
with insulin sensitivity.
In EA, IMCL was extensively correlated with BMI and 
regional measures of adiposity including waist circumference, 
trunk fat, and leg fat. IMCL was not related to measures of adi-
posity in AA. The difference shown in Figure 1c,d between 
the IMCL and waist circumference relationships in AA as 
compared to EA is striking. In EA, IMCL is highly correlated 
with waist circumference, but this relationship is not present 
in AA. It is interesting to note that no differences were seen in 
IMCL content between AA and EA. The finding that IMCL is 
related to waist circumference and other measures of obesity 
in EA but not AA, combined with the reduced VAT and liver 
fat accumulation that is reported in AA (11–13), indicates that 
the shuttling of fat to ectopic stores in response to increased 
obesity and insulin resistance may not occur in AA, in contrast 
to that which is observed in EA. It is important to note that the 
correlations between IMCL and adiposity measures reduced 
to nonsignificant levels when BMI was controlled (data not 
shown). This result is expected, given the high degree of col-
linearity between BMI and other measures of adiposity, and 
does not change our interpretation of the correlations.
Waist circumference was significantly correlated with insu-
lin sensitivity in both EA and AA, but overall percent fat was 
not correlated with insulin sensitivity in either group. When 
controlling for BMI, the correlation between waist circumfer-
ence and insulin sensitivity diminished, however trunk-to-leg 
fat ratio in EA and waist-to-hip ratio in AA were significantly 
correlated with insulin sensitivity after controlling for BMI. 
These findings indicate that insulin sensitivity has a stronger 
relationship with central adiposity than it has with general adi-
posity. Our data are consistent with previous findings that cen-
tral adiposity plays a substantial role in insulin sensitivity and 
cardiometabolic disease risk across ethnicities (27). In 12,814 
AA and EA men and women participating in the ARIC study, 
waist circumference was found to be predictive of developing 
type 2 diabetes over the 9-year study across both ethnicities 
and both genders (31). From the same study, it was reported 
that BMI and waist-to-hip ratio explain 39.9% of the difference 
in relative risk of type 2 diabetes between AA and EA (2). Waist 
circumference, more so than percent fat, was also found to be 
highly correlated with several metabolic syndrome measures 
in both AA and EA adults (32). Furthermore, a study spanning 
Europeans and African-Caribbeans found that waist circum-
ference had the highest impact among several metabolic meas-
ures on glucose tolerance (33). A possible explanation for this 
finding is that waist circumference reflects VAT mass, which 
is known to relate highly to insulin resistance, even in AA, 
who have been shown to store less visceral fat than EA (11); 
however, subcutaneous abdominal fat has also been strongly 
and independently correlated to insulin sensitivity in AA (34). 
Therefore, while mounting evidence links central adiposity to 
insulin resistance and the metabolic syndrome trait cluster in 
AA, it is uncertain whether this relationship is predominantly 
driven by VAT or subcutaneous adipose tissue or a combina-
tion of the two. Since insulin sensitivity was associated with 
central adiposity, but not with overall percent body fat in both 
of our groups, it is tempting to argue that the relationship is 
driven more by VAT than subcutaneous adipose tissue in both 
EA and AA, although this is merely speculative because VAT 
was not assessed in our groups.
The reasons that AA and EA exhibit different relationships 
between IMCL and insulin sensitivity are unknown. One pos-
sible explanation is that intramuscular lipid could be com-
partmentalized differently in AA vs. EA, as has been observed 
in endurance athletes vs. type 2 diabetic individuals. Indeed, 
IMCL accumulation occurs in the skeletal muscle of endurance-
trained individuals and is associated with insulin sensitivity in 
this group (35). Muscle from endurance-trained athletes dis-
plays a storage pattern characterized by lipid in droplets adjacent 
to the mitochondria, presumably providing the athlete with an 
enhanced ability to utilize the lipid as substrate during training. 
Skeletal muscle of type 2 diabetics, on the other hand, contains 
more subsarcolemmal lipid and this accumulation is inversely 
associated with insulin sensitivity (36). Whether different com-
partmentalization of lipids in EA vs. AA could explain the eth-
nic differences we have observed in the relationship between 
IMCL and insulin sensitivity remains to be determined.
Another possible explanation is a difference in skeletal 
muscle fiber type between AA and EA. Insulin resistance 
has recently been related to a higher IMCL content in type I 
(oxidative) muscle fibers more so than in type II (glycolytic) 
muscle fibers (37). Furthermore, AA women were found to 
have a higher percentage of type II muscle fibers than their EA 
counterparts. However, this difference was found to be related 
more to increased general adiposity in this group than to eth-
nic differences (38). Our groups did not differ in adiposity and 
therefore should not be expected to have differences in muscle 
fiber type. Nevertheless, more studies analyzing histochemical 
properties of skeletal muscle in AA vs. EA are needed.
Yet another ethnic difference that may impact insulin sen-
sitivity relates to substrate oxidation. Reduced fatty acid oxi-
dation has been observed in obese AA women, compared to 
EA women, and is related to reduced insulin sensitivity (39). 
Moreover, metabolic inflexibility in substrate use has been 
reported in healthy premenopausal AA women, compared to 
EA women (40). Therefore, the differing relationship between 
IMCL and insulin sensitivity in EA and AA groups may be due 
to differences in substrate flux within skeletal muscle.
A limitation of this study is that the subjects were not 
assessed for aerobic capacity. Maximal aerobic capacity has 
been shown to be an important determinant of tibialis IMCL. 
While VO2max was not significantly related to soleus IMCL, an 
interaction effect was observed between soleus IMCL, VO2max, 
and GDR (17). VO2max data was not available on our subjects; 
however, all subjects were screened to be completely sedentary 
and involved in no regular physical activity or planned exer-
cise. Therefore, it is unlikely that aerobic fitness could entirely 
explain the differences we have found in the relationships 
between soleus IMCL and insulin sensitivity in EA and AA.
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Taken together, our results suggest that, in EA, IMCL is a 
fat depot that closely relates to insulin sensitivity as well as to 
generalized and central adiposity. In AA, however, central adi-
posity is more closely related to insulin resistance. These data 
indicate that IMCL is a determinant of insulin resistance in 
EA but exists largely independent of insulin resistance in AA. 
Clearly, skeletal muscle insulin resistance is less dependent 
upon IMCL accumulation in AA. In both AA and EA, how-
ever, central adiposity is associated with insulin resistance and 
confers increased risk of cardiometabolic disease. These dif-
ferences in metabolic and body composition traits and their 
associations with insulin resistance point to potential racial 
differences in the pathogenesis of the metabolic syndrome. 
Specifically, IMCL may serve as a less relevant pathophysi-
ological role in the development of insulin resistance and the 
metabolic syndrome trait cluster in individuals of African 
descent. Large-scale clinical trials that include analyses for aer-
obic capacity, VAT, and hepatic fat are needed to further assess 
the specific contributions of ectopic fat to insulin resistance in 
individuals of African descent.
acknowLedGMents
We thank the research volunteers for their participation in this study. This 
work was supported from grants from the National Institutes of Health (DK-
038765, DK-083562, PO1 HL-55782), the T32 training grant (HL-007457) 
entitled “Mechanisms of Hypertension and Cardiovascular Diseases” (PI: S. 
Oparil), the T32 training grant (HL-072757) entitled “UAB Statistical Genetics 
Post-Doctoral Training Program” (PI: D.B.A.), and by the Merit Review 
program of the Department of Veterans Affairs. We also acknowledge 
support from the UAB Center for Clinical and Translational Science (UL1 
RR025777), and core facility support from the Clinical Nutrition Research 
Unit (P30-DK56336), and the Diabetes Research and Training Center (P60 
DK079626). We further acknowledge Dr. jan den Hollander at UAB for his 
assistance with IMCL measurements.
dIscLosure
The authors declared no conflict of interest.
© 2011 The Obesity Society
reFerences
1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: 
estimates for the year 2000 and projections for 2030. Diabetes Care 
2004;27:1047–1053.
2. Brancati FL, Kao WH, Folsom AR, Watson RL, Szklo M. Incident type 2 
diabetes mellitus in African American and white adults: the Atherosclerosis 
Risk in Communities Study. JAMA 2000;283:2253–2259.
3. Shai I, Jiang R, Manson JE et al. Ethnicity, obesity, and risk of type 
2 diabetes in women: a 20-year follow-up study. Diabetes Care 
2006;29:1585–1590.
4. Lara-Castro C, Newcomer BR, Rowell J et al. Effects of short-term very  
low-calorie diet on intramyocellular lipid and insulin sensitivity in nondiabetic 
and type 2 diabetic subjects. Metab Clin Exp 2008;57:1–8.
5. Furler SM, Poynten AM, Kriketos AD et al. Independent influences of  
central fat and skeletal muscle lipids on insulin sensitivity. Obes Res 
2001;9:535–543.
6. Jacob S, Machann J, Rett K et al. Association of increased intramyocellular 
lipid content with insulin resistance in lean nondiabetic offspring of type 2 
diabetic subjects. Diabetes 1999;48:1113–1119.
7. Stefan N, Kantartzis K, Machann J et al. Identification and characterization of 
metabolically benign obesity in humans. Arch Intern Med 2008;168: 
1609–1616.
8. Wagenknecht LE, Langefeld CD, Scherzinger AL et al. Insulin sensitivity, 
insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis 
Study (IRAS) Family Study. Diabetes 2003;52:2490–2496.
9. Albu JB, Murphy L, Frager DH, Johnson JA, Pi-Sunyer FX. Visceral fat and 
race-dependent health risks in obese nondiabetic premenopausal women. 
Diabetes 1997;46:456–462.
10. Gower BA, Weinsier RL, Jordan JM, Hunter GR, Desmond R. Effects 
of weight loss on changes in insulin sensitivity and lipid concentrations 
in premenopausal African American and white women. Am J Clin Nutr 
2002;76:923–927.
11. Lara-Castro C, Weinsier RL, Hunter GR, Desmond R. Visceral adipose 
tissue in women: longitudinal study of the effects of fat gain, time, and race. 
Obes Res 2002;10:868–874.
12. Weinsier RL, Hunter GR, Gower BA et al. Body fat distribution in white 
and black women: different patterns of intraabdominal and subcutaneous 
abdominal adipose tissue utilization with weight loss. Am J Clin Nutr 
2001;74:631–636.
13. Liska D, Dufour S, Zern TL et al. Interethnic differences in muscle, liver and 
abdominal fat partitioning in obese adolescents. PLoS ONE 2007;2:e569.
14. Guerrero R, Vega GL, Grundy SM, Browning JD. Ethnic differences in 
hepatic steatosis: an insulin resistance paradox? Hepatology 2009;49: 
791–801.
15. Weston SR, Leyden W, Murphy R et al. Racial and ethnic distribution of 
nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. 
Hepatology 2005;41:372–379.
16. Kuhlmann J, Neumann-Haefelin C, Belz U et al. Intramyocellular lipid and 
insulin resistance: a longitudinal in vivo 1H-spectroscopic study in Zucker 
diabetic fatty rats. Diabetes 2003;52:138–144.
17. Thamer C, Machann J, Bachmann O et al. Intramyocellular lipids: 
anthropometric determinants and relationships with maximal aerobic 
capacity and insulin sensitivity. J Clin Endocrinol Metab 2003;88:1785–1791.
18. Perseghin G, Lattuada G, Danna M et al. Insulin resistance, intramyocellular 
lipid content, and plasma adiponectin in patients with type 1 diabetes. Am J 
Physiol Endocrinol Metab 2003;285:E1174–E1181.
19. Pan DA, Lillioja S, Kriketos AD et al. Skeletal muscle triglyceride levels are 
inversely related to insulin action. Diabetes 1997;46:983–988.
20. Greco AV, Mingrone G, Giancaterini A et al. Insulin resistance in morbid 
obesity: reversal with intramyocellular fat depletion. Diabetes 2002;51: 
144–151.
21. Garvey WT, Olefsky JM, Griffin J, Hamman RF, Kolterman OG. The effect 
of insulin treatment on insulin secretion and insulin action in type II diabetes 
mellitus. Diabetes 1985;34:222–234.
22. Weiss R, Dziura JD, Burgert TS et al. Ethnic differences in beta cell 
adaptation to insulin resistance in obese children and adolescents. 
Diabetologia 2006;49:571–579.
23. Larson-Meyer DE, Smith SR, Heilbronn LK et al.; Look AHEAD Adipose 
Research Group. Muscle-associated triglyceride measured by computed 
tomography and magnetic resonance spectroscopy. Obesity (Silver Spring) 
2006;14:73–87.
24. De Bock K, Dresselaers T, Kiens B et al. Evaluation of intramyocellular lipid 
breakdown during exercise by biochemical assay, NMR spectroscopy, and 
Oil Red O staining. Am J Physiol Endocrinol Metab 2007;293:E428–E434.
25. Naressi A, Couturier C, Devos JM et al. Java-based graphical user interface 
for the MRUI quantitation package. MAGMA 2001;12:141–152.
26. Lara-Castro C, Doud EC, Tapia PC et al. Adiponectin multimers and 
metabolic syndrome traits: relative adiponectin resistance in African 
Americans. Obesity (Silver Spring) 2008;16:2616–2623.
27. Gower BA, Ard JD, Hunter GR, Fernandez J, Ovalle F. Elements of the 
metabolic syndrome: association with insulin sensitivity and effects of 
ethnicity. Metab Syndr Relat Disord 2007;5:77–86.
28. Taylor H, Liu J, Wilson G et al. Distinct component profiles and high risk 
among African Americans with metabolic syndrome: the Jackson Heart 
Study. Diabetes Care 2008;31:1248–1253.
29. Lee S, Guerra N, Arslanian S. Skeletal muscle lipid content and insulin 
sensitivity in black versus white obese adolescents: is there a race 
differential? J Clin Endocrinol Metab 2010;95:2426–2432.
30. White LJ, Ferguson MA, McCoy SC, Kim HW, Castellano V. Cardiovascular/
non-insulin-dependent diabetes mellitus risk factors and intramyocellular lipid 
in healthy subjects: a sex comparison. Metab Clin Exp 2006;55:128–134.
31. Stevens J, Couper D, Pankow J et al. Sensitivity and specificity of 
anthropometrics for the prediction of diabetes in a biracial cohort. Obes Res 
2001;9:696–705.
32. Shen W, Punyanitya M, Chen J et al. Waist circumference correlates with 
metabolic syndrome indicators better than percentage fat. Obesity (Silver 
Spring) 2006;14:727–736.
obesity | VOLUME 19 NUMBER 7 | jULy 2011 1475
articles
epidemiology
33. Riste L, Khan F, Cruickshank K. High prevalence of type 2 diabetes in all 
ethnic groups, including Europeans, in a British inner city: relative poverty, 
history, inactivity, or 21st century Europe? Diabetes Care 2001;24:1377–1383.
34. Tulloch-Reid MK, Hanson RL, Sebring NG et al. Both subcutaneous and 
visceral adipose tissue correlate highly with insulin resistance in african 
americans. Obes Res 2004;12:1352–1359.
35. Dubé JJ, Amati F, Stefanovic-Racic M et al. Exercise-induced alterations in 
intramyocellular lipids and insulin resistance: the athlete’s paradox revisited. 
Am J Physiol Endocrinol Metab 2008;294:E882–E888.
36. Nielsen J, Mogensen M, Vind BF et al. Increased subsarcolemmal lipids 
in type 2 diabetes: effect of training on localization of lipids, mitochondria, 
and glycogen in sedentary human skeletal muscle. Am J Physiol Endocrinol 
Metab 2010;298:E706–E713.
37. Coen PM, Dubé JJ, Amati F et al. Insulin resistance is associated with higher 
intramyocellular triglycerides in type I but not type II myocytes concomitant 
with higher ceramide content. Diabetes 2010;59:80–88.
38. Tanner CJ, Barakat HA, Dohm GL et al. Muscle fiber type is associated with 
obesity and weight loss. Am J Physiol Endocrinol Metab 2002;282: 
E1191–E1196.
39. Cortright RN, Sandhoff KM, Basilio JL et al. Skeletal muscle fat oxidation is 
increased in African-American and white women after 10 days of endurance 
exercise training. Obesity (Silver Spring) 2006;14:1201–1210.
40. Berk ES, Kovera AJ, Boozer CN, Pi-Sunyer FX, Albu JB. Metabolic 
inflexibility in substrate use is present in African-American but not Caucasian 
healthy, premenopausal, nondiabetic women. J Clin Endocrinol Metab 
2006;91:4099–4106.
